140 results
424B3
CYCC
Cyclacel Pharmaceuticals Inc
14 Feb 24
Prospectus supplement
4:06pm
or amendment;
slower than anticipated rates of subject recruitment and enrollment, or not reaching the targeted number of subjects because of competition … product candidates for any or all targeted indications. In addition to this, the product-related side effects could affect patient recruitment
8-K
EX-99.1
cim5je3l
10 Aug 22
Cyclacel Pharmaceuticals Reports SECOND quarter 2022 financial results
4:15pm
8-K
EX-99.1
jn75 fqkq
11 May 22
Cyclacel Pharmaceuticals Reports first quarter 2022 financial results and provides business update
4:11pm
424B5
jrqiukonzeegdv922572
30 Mar 22
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
j4z75rqtbzze edag3p
10 Nov 21
Cyclacel Pharmaceuticals Reports THIRD Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
40e5p9smnd agm7fovtc
11 Aug 21
Cyclacel Pharmaceuticals Reports SECOND Quarter 2021 Financial Results
4:16pm
8-K
EX-99.1
varz21gp79xzdy6ze
12 May 21
Cyclacel Pharmaceuticals Reports FIRST Quarter 2021 Financial Results
4:21pm